Arachidonic Acid Market Size, Share, Growth Analysis, By Form(Solid and Solvent), By Source(Animal and Plant), By Region - Industry Forecast 2024-2031

Arachidonic Acid Market size was valued at USD 212.5 billion in 2021 and is poised to grow from USD 221.85 billion in 2022 to USD 299.89 billion by 2030, at a CAGR of 4.4% during the forecast period (2023-2030).

These companies are actively engaged in the production, research, and development of arachidonic acid, catering to diverse industry sectors such as infant formula, dietary supplements, pharmaceuticals, and food and beverages. They compete based on product quality, innovation, manufacturing capabilities, and market reach. 'BASF SE (Germany)', 'Cargill, Incorporated (United States)', 'Koninklijke DSM N.V. (Netherlands)', 'Cayman Chemical Company (United States)', 'A&Z Food Additives Co., Ltd. (China)', 'Jarrow Formulas, Inc. (United States)', 'GlaxoSmithKline plc (United Kingdom)', 'Lallemand Inc. (Canada)', 'Guangdong Runke Bioengineering Co., Ltd. (China)', 'Guangdong Haid Group Co., Ltd. (China)', 'Nordic Naturals, Inc. (United States)', 'NaturaNectar LLC (United States)', 'Xi'an Lyphar Biotech Co., Ltd. (China)', 'Novotech Nutraceuticals, Inc. (Canada)', 'Nu-Mega Ingredients Pty Ltd (Australia)', 'Xiamen Huison Biotech Co., Ltd. (China)', 'AarhusKarlshamn AB (Sweden)', 'Suzhou Jinyuan Biochemical Co., Ltd. (China)', 'Minasolve (France)', 'Yuwang Pharmaceutical Co., Ltd. (China)'

Growing awareness among consumers about the benefits of arachidonic acid, such as its role in brain development and overall health, is a significant driver. Increased understanding of the importance of nutrition in early childhood and the rising popularity of dietary supplements contribute to market growth.

The market is witnessing a trend towards the incorporation of arachidonic acid into functional foods. Manufacturers are exploring opportunities to incorporate arachidonic acid into a variety of food products, including snacks, beverages, and fortified foods, to cater to the growing demand for convenient and healthy options.

North America holds a high share in the arachidonic acid market. The United States, in particular, dominates the region due to its robust healthcare infrastructure, high consumer spending on health and wellness products, and a well-established market for infant formula. In North America, the dominant segment is the solvent form of arachidonic acid, which finds extensive application in infant formula and dietary supplements. The region is witnessing steady growth, driven by increasing consumer awareness and the presence of major market players.